These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2977182)

  • 1. Long-term antihypertensive treatment may induce normalization of left ventricular mass before complete regression of vascular structural changes: consequences for cardiac function at rest and during stress.
    Agabiti-Rosei E; Muiesan ML; Geri A; Romanelli G; Beschi M; Castellano M; Muiesan G
    J Hypertens Suppl; 1988 Dec; 6(4):S94-6. PubMed ID: 2977182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between cardiac hypertrophy and forearm vascular structural changes before and during long-term antihypertensive treatment.
    Agabiti-Rosei E; Muiesan ML; Geri A; Romanelli G; Montani G; Muiesan G
    Am J Med; 1988 Mar; 84(3A):125-8. PubMed ID: 2975461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
    J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
    Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
    Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular systolic function in relation to withdrawal of different pharmacological treatments in hypertensives with left ventricular hypertrophy.
    Muiesan ML; Agabiti-Rosei E; Romanelli G; Alari G; Barbier P; Fiorentini C; Muiesan G
    J Hypertens Suppl; 1988 Dec; 6(4):S97-100. PubMed ID: 2977183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of one year's treatment with captopril on left ventricular anatomy and function in hypertensive patients with left ventricular hypertrophy.
    Muiesan ML; Agabiti-Rosei E; Romanelli G; Castellano M; Beschi M; Muiesan G
    Am J Med; 1988 Mar; 84(3A):129-32. PubMed ID: 2975462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved left ventricular systolic and diastolic function after regression of cardiac hypertrophy, treatment withdrawal, and redevelopment of hypertension.
    Muiesan ML; Agabiti-Rosei E; Romanelli G; Beschi M; Castellano M; Alari G; Rizzoni D; Muiesan G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S179-81. PubMed ID: 1715477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects.
    Spratt JC; Webb DJ; Shiels A; Williams B
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):227-32. PubMed ID: 11881128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL; Willard DA
    J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
    du Cailar G; Fesler P; Ribstein J; Mimran A
    Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
    González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
    Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
    Vogt M; Kreutz KU; Motz W; Strauer BE
    Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
    Agabiti-Rosei E; Trimarco B; Muiesan ML; Reid J; Salvetti A; Tang R; Hennig M; Baurecht H; Parati G; Mancia G; Zanchetti A;
    J Hypertens; 2005 May; 23(5):1091-8. PubMed ID: 15834297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antihypertensive treatment on cardiac hypertrophy and cardiac function in elderly hypertensive patients.
    Nagano N; Iwatsubo H; Hata T; Mikami H; Ogihara T
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S163-5. PubMed ID: 1715472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
    Fernandez PG; Snedden W; Nath C; Vasdev S; Lee C; Darke A
    Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.